Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Parth Mehrotra is Chief Executive Officer at Privia Health Group, Inc.. OQRO lists 7 transactions filed with the SEC under this name, the latest on May 14, 2025, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
7
Companies involved
1
Privia Health Group, Inc.PRVA
7 disclosures · Mar 2025 – May 2025 · 7 sold
May 13, 2025Sold~$390Kdisclosed May 14
DetailsOfficial recordMay 12, 2025Sold~$344Kdisclosed May 14
DetailsOfficial recordMay 1, 2025Sold~$401Kdisclosed May 2
DetailsOfficial recordApr 30, 2025Sold~$352Kdisclosed May 2
DetailsOfficial recordMar 12, 2025Sold~$253Kdisclosed Mar 14
DetailsOfficial recordMar 10, 2025Sold~$236Kdisclosed Mar 12
DetailsOfficial recordMar 11, 2025Sold~$222Kdisclosed Mar 12
DetailsOfficial recordParth Mehrotra has no open-market purchase on record since 2021. Sales in each of the last 5 years.
Parth Mehrotra reported 0 open-market purchases and 89 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $2.2M7×7 trades |
| 2024 | — | $2.97M3×3 trades |
| 2023 | — | $20.6M30×30 trades |
| 2022 | — | $61.2M42×42 trades |
| 2021 | — | $5.39M7×7 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Parth Mehrotra reported 0 open-market purchases and 89 sales here, 2021 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Parth Mehrotra reported holding 407,234 shares of Privia Health Group, Inc. (PRVA), worth about $10M at the last close of $25 (Nov 13, 2026).
Privia Health Group, Inc.'s proxy statement reports total compensation of $9.24M for Parth Mehrotra for fiscal year 2025, after $8.2M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 2, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Privia Health Group, Inc. PRVA | 407,234 | 407K direct | $25 | $10M | May 13, 2025 |
Is this Parth Mehrotra’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated May 13, 2025, Parth Mehrotra reported holding 407,234 shares of Privia Health Group, Inc. (PRVA). At the last close of $25 on Nov 13, 2026, that is about $10M. This is the stake disclosed in filings, not a net worth.
Privia Health Group, Inc.'s proxy statement reports total compensation of $9.24M for Parth Mehrotra for fiscal year 2025, after $8.2M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Parth Mehrotra has no open-market purchase on record since 2021. Sales in each of the last 5 years.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2025.
Privia Health Group, Inc. (PRVA), from 2021 to 2025: 0 purchases and 89 sales.